1. Home
  2. FN vs BNTX Comparison

FN vs BNTX Comparison

Compare FN & BNTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Fabrinet

FN

Fabrinet

HOLD

Current Price

$495.51

Market Cap

20.3B

Sector

Utilities

ML Signal

HOLD

Logo BioNTech SE

BNTX

BioNTech SE

HOLD

Current Price

$97.41

Market Cap

24.2B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
FN
BNTX
Founded
1999
2008
Country
Cayman Islands
Germany
Employees
N/A
N/A
Industry
Telecommunications Equipment
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Utilities
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
20.3B
24.2B
IPO Year
2007
2019

Fundamental Metrics

Financial Performance
Metric
FN
BNTX
Price
$495.51
$97.41
Analyst Decision
Buy
Strong Buy
Analyst Count
8
13
Target Price
$513.43
$133.46
AVG Volume (30 Days)
851.2K
966.8K
Earning Date
05-04-2026
05-05-2026
Dividend Yield
N/A
N/A
EPS Growth
13.21
N/A
EPS
9.22
N/A
Revenue
$3,419,327,000.00
N/A
Revenue This Year
$36.87
N/A
Revenue Next Year
$17.91
$3.37
P/E Ratio
$54.10
N/A
Revenue Growth
18.60
N/A
52 Week Low
$272.49
$79.81
52 Week High
$748.89
$124.00

Technical Indicators

Market Signals
Indicator
FN
BNTX
Relative Strength Index (RSI) 35.70 64.21
Support Level $485.34 $95.13
Resistance Level $508.51 $112.93
Average True Range (ATR) 39.17 2.32
MACD -6.24 0.91
Stochastic Oscillator 6.39 87.63

Price Performance

Historical Comparison
FN
BNTX

About FN Fabrinet

Fabrinet provides advance-level optical packaging and precision optical, electro-mechanical, and electronic manufacturing services to original equipment manufacturers of complex products, such as optical communication components, modules and sub-systems, industrial lasers, automotive components, medical devices, and sensors. The company offers a broad range of advance optical and electro-mechanical capabilities across the entire manufacturing process, including process design and engineering, supply chain management, manufacturing, complex printed circuit board assembly, advance-level of packaging, integration, final assembly, and testing. The company generates the majority of its revenue from North America and Asia-Pacific, with the rest from Europe.

About BNTX BioNTech SE

BioNTech is a Germany-based biotechnology company that focuses on developing cancer therapeutics, including individualized immunotherapy, as well as vaccines for infectious diseases, including covid. The company's oncology pipeline contains several classes of drugs, including mRNA-based drugs to encode antigens and neoantigens; monospecific and bispecific antibodies; and antibody-drug conjugates, or ADCs. Comirnaty, its Pfizer-partnered covid vaccine, is its first commercialized product.

Share on Social Networks: